Biocon arm Syngene ends contract with Bioinnovat Research over graft case

Guljit Sethi of Bioinnovat research was named in CBI FIR on a bribery case involving CDSCO official and Biocon Biologics executive

After the controversy surrounding Central Drugs Standards Control Organisation (CDSCO) and Biocon Biologics emerged, another Biocon Group arm Syngene International has distanced itself from Bioinnovat Research Services, whose promoter has been mentioned in the anti-graft case. The company has terminated its retainer advisory contract with Bioinnovat recently.

Syngene International, the research, development and manufacturing organisation (CRDMO) that serves global pharmaceutical, biotech clients among others, has terminated the contract it had with Bioinnovat.

Guljit Sethi (alias Guljit Chaudhary), Bioinnovat Research Services was arrested by the Central Bureau of Investigation (CBI) in connection to the bribery case that involved joint drugs controller